Altogether, these results indicate that AsA treatment could effectively inhibit lung cancer cell growth in vitro and in vivo, and the mechanistic study showed that AsA induced G1/S cell cycle arrest by upregulating ROS and decreasing p-Akt (Figure 6f). Here, AKT1 is linked to lung carcinoma.